DE3574968D1 - 11-substituierte-16-phenoxy und 16-phenoxysubstituierte prostatriensaeurederivate. - Google Patents

11-substituierte-16-phenoxy und 16-phenoxysubstituierte prostatriensaeurederivate.

Info

Publication number
DE3574968D1
DE3574968D1 DE8585109580T DE3574968T DE3574968D1 DE 3574968 D1 DE3574968 D1 DE 3574968D1 DE 8585109580 T DE8585109580 T DE 8585109580T DE 3574968 T DE3574968 T DE 3574968T DE 3574968 D1 DE3574968 D1 DE 3574968D1
Authority
DE
Germany
Prior art keywords
phenoxy
substituted
hydrogen
prostatric
acid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585109580T
Other languages
English (en)
Inventor
Gary F Cooper
John H Fried
David Waterbury
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Application granted granted Critical
Publication of DE3574968D1 publication Critical patent/DE3574968D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8585109580T 1984-07-31 1985-07-30 11-substituierte-16-phenoxy und 16-phenoxysubstituierte prostatriensaeurederivate. Expired - Fee Related DE3574968D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63597084A 1984-07-31 1984-07-31

Publications (1)

Publication Number Publication Date
DE3574968D1 true DE3574968D1 (de) 1990-02-01

Family

ID=24549856

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585109580T Expired - Fee Related DE3574968D1 (de) 1984-07-31 1985-07-30 11-substituierte-16-phenoxy und 16-phenoxysubstituierte prostatriensaeurederivate.

Country Status (10)

Country Link
EP (1) EP0170258B1 (de)
JP (1) JPS6147459A (de)
AT (1) ATE48991T1 (de)
AU (1) AU573018B2 (de)
DE (1) DE3574968D1 (de)
DK (1) DK346085A (de)
ES (1) ES8607921A1 (de)
HU (1) HU196174B (de)
NZ (1) NZ212914A (de)
ZA (1) ZA855740B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804787A (en) * 1983-12-22 1989-02-14 Syntex (U.S.A.) Inc. Processes and intermediates for making 16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives
US4600785A (en) * 1983-12-22 1986-07-15 Syntex (U.S.A.) Inc. Processes and intermediates for making 16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives
US4912235A (en) * 1983-12-22 1990-03-27 Syntex (U.S.A.) Inc. Processes and intermediates for making 16-phenoxy- and 16-substituted phenoxy-prostatrienoic acid derivatives and their stereoisomers
US5057621A (en) * 1984-07-31 1991-10-15 Syntex (U.S.A.) Inc. 11-substituted-16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives
US4618696A (en) * 1984-07-31 1986-10-21 Syntex (U.S.A.) Inc. 9-oxo-15α-hydroxy-16-phenoxy and 16-substituted phenoxy 17,18,19,20-tetranorprosta-4,5,13,(E)-trienoates
DE3570073D1 (en) * 1984-10-09 1989-06-15 Syntex Inc Intermediates for making 16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives
AU586658B2 (en) * 1984-12-24 1989-07-20 Syntex (U.S.A.) Inc. Uses for enprostil
US5236907A (en) * 1988-10-01 1993-08-17 R-Tech Ueno Ltd. Ocular hypotensive agents
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP1300151A3 (de) * 1988-09-06 2003-05-14 Pharmacia Aktiebolag Prostaglandin-Derivate zur Behandlung von Glaukom oder Augenüberdruck
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
DE68929435T2 (de) * 1988-09-06 2003-07-17 Pharmacia Ab Prostaglandinderivate zur Behandlung des grünen Stars oder einer okularen Hypertension
JP3164368B2 (ja) * 1990-03-08 2001-05-08 塩野義製薬株式会社 １５―デオキシプロスタグランジン誘導体
CA2138181A1 (en) * 1993-12-15 1995-06-16 Verney L. Sallee Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
DE69823852T2 (de) 1997-02-04 2005-05-19 Johnstone, Murray A., Seattle Verfahren zur förderung des haarwuchses und entwicklung des haarsystems
AU2211700A (en) * 1998-12-24 2000-07-31 Alcon Laboratories, Inc. Prostaglandin e agonists for treatment of glaucoma
HUP0200258A2 (hu) 1999-03-05 2002-05-29 The Procter & Gamble Co. C16-telítetlen FP-szelektív prosztaglandin analógok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US20050239872A1 (en) * 2002-06-06 2005-10-27 Xavier Billot 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma
US7642370B2 (en) 2006-08-07 2010-01-05 Daiichi Fine Chemical Co., Ltd. Method for preparing prostaglandin derivative
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
MX361709B (es) 2009-11-09 2018-12-07 Allergan Inc Composiciones y metodos para estimular el crecimiento del cabello.
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3989744A (en) * 1973-07-30 1976-11-02 Miles Laboratories, Inc. 11-Substitute d-11-desoxy-pge analogues
US4178457A (en) * 1978-07-10 1979-12-11 Syntex (U.S.A.) Inc. (dl)-16-Phenoxy- and 16-substituted phenoxy-9-keto prostatrienoic acid derivatives and processes for the production thereof
US4618696A (en) * 1984-07-31 1986-10-21 Syntex (U.S.A.) Inc. 9-oxo-15α-hydroxy-16-phenoxy and 16-substituted phenoxy 17,18,19,20-tetranorprosta-4,5,13,(E)-trienoates

Also Published As

Publication number Publication date
HU196174B (en) 1988-10-28
ES545700A0 (es) 1986-06-16
ES8607921A1 (es) 1986-06-16
DK346085A (da) 1986-02-01
EP0170258B1 (de) 1989-12-27
ATE48991T1 (de) 1990-01-15
NZ212914A (en) 1988-08-30
EP0170258A3 (en) 1986-09-10
DK346085D0 (da) 1985-07-30
EP0170258A2 (de) 1986-02-05
ZA855740B (en) 1987-03-25
JPS6147459A (ja) 1986-03-07
AU573018B2 (en) 1988-05-26
HUT38309A (en) 1986-05-28
AU4562085A (en) 1986-02-06

Similar Documents

Publication Publication Date Title
DE3574968D1 (de) 11-substituierte-16-phenoxy und 16-phenoxysubstituierte prostatriensaeurederivate.
ATE45354T1 (de) Chinoloncarbonsaeurederivate.
PH23448A (en) Quinoline compounds
ES2031892T3 (es) Agentes antialergicos y antiinflamatorios.
ES8504723A1 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolonas.
ES2046229T3 (es) Composicion antiulcerosa.
IN165718B (de)
NZ220338A (en) 2-benzoyl-1,3,5-cyclohexanetrione derivatives and herbicidal compositions
ES8607922A1 (es) Procedimiento para preparar 9-oxo-15 a-hidroxi-16-fenoxi y 16-fenoxi sustituido-17,18,19,20-tetranorprosta-4,5,13 (e)- trienoatos
NO903514L (no) Imidazolderivat og fremgangsmaate til dets fremstilling.
ATE53833T1 (de) Derivate des phenylacetanilids.
SG136194G (en) Novel benzoxazolone compounds and the use thereof as microbicides
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
ATE52514T1 (de) S-aralkyltrithiophosphonat-insektizide.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee